# NYSTATIN AND TRIAMCINOLONE ACETONIDE
> **ANDA214186** · Abbreviated New Drug Application (Generic) · Sponsor: ALEMBIC · Approved 2022-03-04
## Drug
- **FDA Application Number:** ANDA214186
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN AND TRIAMCINOLONE ACETONIDE
- **Generic name:** NYSTATIN AND TRIAMCINOLONE ACETONIDE
- **Active ingredients:** NYSTATIN; TRIAMCINOLONE ACETONIDE
- **Dosage form:** OINTMENT
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** ALEMBIC
- **Manufacturer:** Alembic Pharmaceuticals Inc.
- **First approval:** 2022-03-04
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214186)
---
*MORVS · CC0 1.0*